LONDON, Sept. 23, 2021 /PRNewswire/ -- VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) platform originating from Imperial College London, today announces a collaboration with AstraZeneca to progress the company's...
from PR Newswire: https://ift.tt/3zE6rNT
No comments:
Post a Comment